Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | BDKRB2 | P30411 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30406844 | 0.98 | DNM1 (0.41) | DNM1BDKRB2ALDH1A1EPHX1FDPS | |
| Bromide SCHEMBL7135405 | 0.92 | DNM1 (0.40) | DNM1BDKRB2ALDH1A1EPHX1 | |
| SCHEMBL31447354 | 0.90 | DNM1 (0.38) | DNM1BDKRB2ALDH1A1EPHX1 | |
| SCHEMBL2104204 | 0.77 | ALDH1A1 (0.41) | DNM1ALDH1A1EPHX1FDPS | |
| SCHEMBL2102512 | 0.75 | MAPT (0.34) | DNM1ALDH1A1EPHX1FDPS | |
| SCHEMBL2104299 | 0.73 | ALDH1A1 (0.39) | ALDH1A1EPHX1 | |
| SCHEMBL2101964 | 0.73 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL2101832 | 0.73 | LMNA (0.43) | DNM1ALDH1A1EPHX1 | |
| Hydrochloric Acid SCHEMBL1056720 | 0.72 | ALDH1A1 (0.45) | DNM1BDKRB2ALDH1A1EPHX1 | |
| SCHEMBL2101976 | 0.72 | LMNA (0.47) | DNM1ALDH1A1EPHX1SPHK2SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12532662-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2026-01-20 | — | — | US | disclosed |
| US-20250255180-A1 | ORGANIC MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME | Raynergy Tek Incorporation (TW) | 2025-08-07 | — | — | US | disclosed |
| US-20250206974-A1 | ELECTRO-OPTIC INK COMPOSITION, COMPOUND, ELECTRO-OPTIC FILM, AND ELECTRO-OPTIC ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-119978278-A | D-A covalent organic framework based on asymmetric benzothiadiazole ligand and preparation method and application thereof | 山东师范大学 | 2025-05-13 | — | — | CN | disclosed |
| US-20240309240-A1 | POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE | FUJIMI INCORPORATED (JP) | 2024-09-19 | — | — | US | disclosed |
| CN-118575603-A | Ink composition and photoelectric conversion element using same | 住友化学株式会社 | 2024-08-30 | — | — | CN | disclosed |
| US-20240122055-A1 | ORGANIC SEMICONDUCTING COMPOUND AND ORGANIC OPTOELECTRONIC DEVICES USING THE SAME | Raynergy Tek Incorporation (TW) | 2024-04-11 | — | — | US | disclosed |
| CN-117720709-A | Organic semiconductor compound and organic photoelectric element comprising same | 天光材料科技股份有限公司 | 2024-03-19 | — | — | CN | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| CN-112352328-B | Organic semiconductor compound | 天光材料科技股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-1424942-A4 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | UNIV MONTANA STATE (US) | 2005-11-23 | — | — | EP | disclosed |
| US-6953570-B2 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | MONTANA STATE UNIVERSITY (US) | 2005-10-11 | — | — | US | disclosed |
| EP-1424942-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | Montana State University-Bozeman (US) | 2004-06-09 | — | — | EP | disclosed |
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | NICKEL JOINT TRUST, THE | 2003-06-05 | — | — | US | disclosed |
| WO-2003017846-A1 | PORPHYRINS WITH ENHANCED MULTI-PHOTON ABSORPTION CROSS-SECTIONS FOR PHOTODYNAMIC THERAPY | MONTANA STATE UNIVERSITY-BOZEMAN (US) | 2003-03-06 | — | — | WO | disclosed |
| US-5391569-A | Treating osteoporosis, inflammatory disorders | ADIR ET COMPAGNIE (FR) | 1995-02-21 | — | — | US | disclosed |
| US-5247042-A | ISOTROPIC ACRYLIC POLYMER EXHIBITING NONLINEAR OPTICAL RESPONSE | HOECHST CELANESE CORP. | 1993-09-21 | — | — | US | disclosed |
| US-5044725-A | Polymeric thin film waveguide media | HOECHST CELANESE CORP. (US) | 1991-09-03 | — | — | US | disclosed |
| US-5002361-A | Polymeric thin film waveguide media | HOECHST CELANESE CORP. (US) | 1991-03-26 | — | — | US | disclosed |
| WO-1991003504-A1 | ACRYLIC POLYMERS EXHIBITING NONLINEAR OPTICAL RESPONSE | HOECHST CELANESE CORPORATION (US) | 1991-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839155-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | DNM1 2328/4885BDKRB2 4618/4885ALDH1A1 2672/4885 |
| US-20030105070-A1 | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy | HMBS, PPOX, PAICS | DNM1 2187/4885BDKRB2 1987/4885ALDH1A1 2239/4885 |
| US-12532662-B2 | Organic semiconducting compounds | OXER1, BMI1, CRY2 | DNM1 1805/4885BDKRB2 3759/4885ALDH1A1 639/4885 |
| US-20250255180-A1 | ORGANIC MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME | OCIAD1, PPOX, OR51E2 | DNM1 1849/4885BDKRB2 2854/4885ALDH1A1 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.